7,624.27

+44.20

+0.58%

52,306.14

+535.83

+1.03%

25,611.95

+174.95

+0.69%

2,838.43

+26.59

+0.95%

4.8820

-0.0470

-0.95%

18.91

-0.51

-2.63%

3,978.10

+79.20

+2.03%

77,331.47

-688.53

-0.88%

Crude Oil Dec 26

96.83

-7.29

-7.00%

US Private Equity

10,850.63

-82.20

-0.75%

NasdaqCM - Delayed Quote USD

PAVmed Inc. (PAVMZ)

0.0009 -0.0006 (-40.00%)

As of April 30 at 4:00:00 PM EDT. Market Open.

How The PAVmed (PAVM) Narrative Is Shifting After The Latest Analyst Reassessment

Simply Wall St. 6mo ago

PAVM

PAVMZ
-40.00%
PAVmed to Hold Third Quarter 2026 Business Update Conference Call and Webcast on November 13, 2026

PR Newswire 3d ago

PAVM

LUCD
Lucid Diagnostics to Hold Third Quarter 2026 Business Update Conference Call and Webcast on November 12, 2026

PR Newswire 4d ago

LUCD

PAVM
Lucid Diagnostics Begins Receiving Medicare Reimbursement for EsoGuard® and Closes $15 Million Financing

PR Newswire 10d ago

LUCD

PAVM
Lucid Diagnostics Advances Multiple EsoGuard® and EsoCheck® Payment, Billing and Coding Pathways

PR Newswire 1mo ago

LUCD

PAVM
PAVmed (PAVM) Q2 2026 Earnings Call Transcript

Motley Fool 2mo ago

PAVM
PAVmed Inc (PAVM) (Q2 2026) Earnings Call Highlights: Narrowing Losses and Strategic Progress ...

GuruFocus.com 2mo ago

PAVM
PAVmed Inc. Q2 2026 Earnings Call Summary

Moby 2mo ago

NVDA

LUCD

PAVM
PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results

PR Newswire 2mo ago

PAVM

LUCD

VRS.AX
Lucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial Results

PR Newswire 2mo ago

LUCD

PAVM
Lucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard® Esophageal DNA Test

PR Newswire 2mo ago

PAVM

LUCD
Lucid Diagnostics to Participate in Upcoming Investor Conferences

PR Newswire 2mo ago

LUCD

PAVM

Mobilize your Website

View Site in Mobile | Classic

Share by: